Adaptimed develops wearable
single-use sensors and software for continuous vital-sign monitoring outside ICU settings — in EDs, ambulances, step-down units and community care. Our devices prioritize patient comfort
clinical reliability and ease of use, combining validated biosensors with intuitive dashboards and secure data integration to detect deterioration earlier, reduce unnecessary interventions and streamline workflows. We collaborate with clinicians to ensure real-world fit, regulatory compliance and IT integration.
The Benefits
-
Saving 2-3 months on the critical path for clinical trial supply by replacing multiple processes with one operation
-
Reducing manufacturing costs for clinical trial supply by 30-50% - by simplifying the manufacturing process
-
Enabling rapid re-supply after a dose change, reducing total clinical trial elapsed times by eliminating 3-4 months
Core Technology Features
AdaptiMed utilises advanced 3D printing technology specifically designed for pharmaceutical applications. Our system allows for precise dosing and rapid formulation adjustments without the need for traditional manufacturing retooling.
Our Supporters
